2024年8月4日 · Trimetazidine (TMZ) is a medication used to treat heart-related conditions like angina. It helps metabolize fatty acids, which helps your body use oxygen. The drug allows...

曲美他嗪 （trimetazidine）是一种治疗 心绞痛 的药物，已被冠以许多种商品名销售。 [1] 该药物是由法国 Laboratoires Servier （英语：Laboratoires Servier） 开发和销售的第一种 细胞保护性 抗缺血剂。 它是一种抗缺血（抗心绞痛）代谢剂，通过抑制 脂肪酸代谢 来改善 心肌 （英语：myocardial） 葡萄糖的利用，也称为脂肪酸氧化抑制剂。 曲美他嗪通常被用于心绞痛的长期治疗，在一些国家（如 法国）还用于治疗 耳鸣 与 头晕。 欧洲药品管理局 （EMA）于2012年完成 …

Temozolomide (NSC 362856) 是一种可透过血脑屏障的口服活性的 DNA 烷基化 (DNA alkylating) 剂。 Temozolomide 也是一种促自噬 (autophagy) 和促凋亡剂 (apoptosis)。 Temozolomide 对以低水平的 O6-烷基鸟嘌呤 DNA 烷基转移酶 (OGAT) 和功能失配修复系统为特征的肿瘤细胞有效。 Temozolomide 具有抗肿瘤和抗血管生成作用。 * Please select Quantity before adding items. • Nat Photonics. 2024 Jan 18. • Cell Discov. 2023 Aug 29;9 (1):90. [Abstract]

2025年1月7日 · TMZ MR is indicated for the symptomatic treatment of stable angina pectoris in patients inadequately controlled or intolerant to first line therapies. Patients should be counselled regarding the risk of use with reduced renal or hepatic function, worsening of extrapyramidal symptoms or other movement disorders, and risk of falls.

Trimetazidine (TMZ) is the generic name for the chemical that acts as a vasodilator and was discovered over 50 years ago (1970s). TMZ is commonly prescribed in Europe and Russia where it is taken as a pill or in delayed-release tablets to treat angina as well as vertigo, tinnitus, and certain visual disturbances.

2025年2月11日 · Timzid-MR Tablet is an anti-anginal medicine used for treating heart-related chest pain (angina). It prevents new attacks of angina but does not stop an acute attack once it has started. It can be used alone or in combination with some other medicines. Timzid-MR Tablet should be taken regularly as advised by the doctor.

2015年5月12日 · Trimetazidine is a piperazine derivative indicated as an adjunct therapy in symptomatic treatment of stable angina pectoris. Trimetazidine is not FDA approved. However, it has been approved in France since 1978. 10. The next evolution of DrugBank is here. Designed for scientists, driven by AI, and powered by real-time insights.

Temozolomide is an alkylating agent used to treat glioblastoma multiforme and refractory anaplastic astrocytoma. Refractory anaplastic astrocytoma (WHO grade III) and Glioblastoma multiforme (WHO grade IV) are primary malignant brain tumours with poor prognosis and limited treatment options.

2022年3月15日 · Temozolomide 100 mg hard capsules - Summary of Product Characteristics (SmPC) by Ranbaxy (UK) Limited a Sun Pharmaceutical Company

Temozolomide is used in the treatment of malignant melanoma, Hodgkin’s disease, multiple myeloma, brain tumor, blood cancer, breast cancer, non-small cell lung cancer, ovarian cancer and lung cancer. Temozolomide is an anti-cancer medication. It enters the brain tissues and works by damaging the genetic material (DNA and RNA) of the cancer cells.